We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

Trending News

A baby laying down.

No Adverse Health Risks From Steroids Used for Pre-Term Birth, Study Finds

A ginger haired woman leaning over the arm of a chair.

Scientists Identify Brain Circuit That Suppresses Appetite During Nausea

Immunotherapy attacking a cancer cell.

Immunotherapy Combination Approved for Non-Muscle Invasive Bladder Cancer

Psilocybin Shows Promise for Treatment-Resistant Depression – But Is It Safe?

Phage Therapies for Multidrug-Resistant Infections Should Consider Host Response

First Use of CRISPR-Cas9 Gene Editing in Kissing Bugs

News

Using Gene-editing Technology for Faster, Cheaper Antiviral Drug Development

UCLA scientists are working to develop special screening libraries based on a gene-editing technology called CRISPR.

LDC and Boehringer Ingelheim Join Forces

Company has signed agreement with Boehringer Ingelheim and Max Planck Innovation to discover a novel approach for the treatment of Schizophrenia.

MilliporeSigma Expands Bio Production

Company has announced the expansion of its single use cGMP facility with the addition of the Mobius® 2000L single-use bioreactor.

Pro Mach Acquires NJM Packaging

Company has announced acquisition of NJM Packaging to expends its pharmaceutical packaging capabilities and integrated solution offering.

Transplant Genomics Announces Collaboration with Astellas

Collaboration aims to use its TruGraf post-kidney transplant blood test to evaluate renal transplant patient outcomes as part of a clinical trial being run by Astellas.

CyTuVax Reports Interim Results of the Phase I Clinical Trial

Company has reported the interim results of a phase I clinical trial assessing the safety and efficacy of Hepatitis B HBAI20 vaccine for non- responders.

Galapagos Starts Phase 1 Study

Company has announced the start of a Phase 1 study with potentiator GLPG2451 for cystic fibrosis (CF).

Investigational Malaria Vaccine Protects Healthy U.S. Adults

Researchers at NIH have found that the malaria vaccine protected a small number of healthy, malaria-naïve adults in the U.S. from infection for more than one year after immunization.

First Patient Dosed in Phase II Clinical Trial in SAH

Company has announced the first patient has been dosed in the company’s Phase II clinical trial of SFX-01.

'Kidney on a Chip' Facilitates Safer Drug Dosing

University of Michigan researchers have used a "kidney on a chip" device to mimic the flow of medication through human kidneys and measure its effect on kidney cells.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter